◆ 会议时间：2023年5月16日至20日
◆ 会议地点：美国 洛杉矶
◆ 会议简介：
2023年第26届美国基因与细胞治疗学会(ASGCT)年会将于2023年5月16日至20日在美国洛杉矶举行。ASGCT年会是全球基因和细胞治疗领域规模最大的学术会议，为与会者提供了一个介绍最新基因与细胞疗法的发展以及提出并进行批判性讨论的国际平台。作为全球领先的基因与细胞治疗学会议，ASGCT年会吸引了近3500名来自世界各地的专业人士与会，与会者包括科学家、医生、患者和支持者等等（2021年虚拟会议有近6800余名代表参与）。
美国基因与细胞治疗学会(ASGCT)成立于1996年，是全球最大的专业从事基因和细胞治疗研究的非赢利性医学组织，是世界基因与细胞治疗领域最具权威性与公信力的机构，在全球拥有超过2500名成员。ASGCT宣设有癌症治疗、心血管和遗传委员会等若干个科学委员会。——未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）。
ASGCT 2023 - 26th Annual Meeting
of the American Society of Gene & Cell Therapy
Date: May 16-20, 2023
Venue: Los Angeles Convention Center, Los Angeles, CA, USA
摘要征文投稿：
Important Dates
- Abstract submissions open: November 14, 2022 – February 3, 2023 (Please note: There will be no abstract extension this year.)
- Late-breaking abstract submission open: February 13 – March 17
- Abstract notifications sent: April 10, 2023
- Travel Award notifications sent: April 10, 2023
- Withdrawal deadline: April 10, 2023
点此提交摘要>>>Submit Abstract>>>
ASGCT2023 注册费
Annual Meeting Registration |
|
Early bird
(mid-Dec.-Feb. 28) |
Advanced
(March 1-May 12) |
Regular
(May 13 through on-demand period) |
Member (incl. transitional) |
$650 |
$750 |
$950 |
Associate Member |
$300 |
$400 |
$600 |
Nonmember |
$1,000 |
$1,100 |
$1,300 |
Nonmember Government Employee |
$700 |
$800 |
$1,000 |
Nonmember Student/Trainee |
$400 |
$500 |
$700 |
| Closing Night Reception |
$100 |
$100 |
$100 |
Workshop Registration (Each)
Please note that you must be registered for the annual meeting to add on a workshop. |
|
Early bird
(mid-Dec.-Feb. 28) |
Advanced
(March 1-May 12) |
Regular
(May 13 through on-demand period) |
Member (incl. transitional) |
$100 |
$200 |
$300 |
Associate Member |
$50 |
$150 |
$250 |
Nonmember |
$200 |
$300 |
$400 |
Nonmember Government Employee |
$125 |
$225 |
$325 |
Nonmember Student/Trainee |
$75 |
$175 |
$275 |
Annual Meeting registrants may change their registration selection between the in-person and virtual meeting without penalties or change fees by Friday, May 5, 2023.
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
